Cover Image
Market Research Report
Product code 
1109457

MONKEYPOX DIAGNOSTICS Global Markets by Assay, by Country, by Product, and by Place. With Executive and Consultant Guides and Market Analysis and Forecasts 2022 - 2026

Published: | Howe Sound Research | 294 Pages | Delivery time: 1-2 business days

Price

Back to Top
MONKEYPOX DIAGNOSTICS Global Markets by Assay, by Country, by Product, and by Place. With Executive and Consultant Guides and Market Analysis and Forecasts 2022 - 2026
Published: August 4, 2022
Howe Sound Research
Content info: 294 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

OVERVIEW:

Monkeypox is being declared a health emergency. Latest data show the outbreak into non-African regions is expanding at alarming rates. Governments around the world are preparing to use widespread testing to get in front of this threat from the beginning. Opportunities abound for the In Vitro Diagnostic Industry.

The report forecasts the market size out to 2026. Growth is coming from the basic factors but the COVID Pandemic has changed to market landscape now and for the foreseeable future. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnostics and the Genomics Revolution are merging to create new diagnostic opportunities.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

  • 2.1. An Overview of Monkeypox Diagnostics
    • 2.1.1. The 2022 Outbreak
  • 2.2. Market Definition
    • 2.2.1. Market Size
    • 2.2.2. Currency
    • 2.2.3. Years
    • 2.2.4. PCR
    • 2.2.5. NGS
    • 2.2.6. Syndromic PoC
    • 2.2.7. Biomarkers Molecular Diagnostics
    • 2.2.8. Biomarkers Other
    • 2.2.9. Limitations
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Monkeypox-Current Science

  • 3.1. What is Monkeypox?
  • 3.2. Outbreaks
  • 3.3. Transmission
  • 3.4. Signs and symptoms
  • 3.5. Diagnosis
  • 3.6. Therapeutics
    • 3.6.1. Vaccination
    • 3.6.2. Prevention
  • 3.6.2.1. Reducing the risk of human-to-human transmission
  • 3.6.2.2. Reducing the risk of zoonotic transmission
  • 3.7. How monkeypox relates to smallpox

4. Industry Overview

  • 4.1. Players in a Dynamic Market
    • 4.1.1. Academic Research Lab
    • 4.1.2. Diagnostic Test Developer
    • 4.1.3. Pharmaceutical/Reagent Supplier
    • 4.1.4. Independent Testing Lab
    • 4.1.5. Public National/regional lab
    • 4.1.6. Hospital lab
    • 4.1.7. Physician Lab
    • 4.1.8. Audit Body
    • 4.1.9. Certification Body

5. Market Trends

  • 5.1. Factors Driving Growth
    • 5.1.1. Prevalence
    • 5.1.2. Surveillance
    • 5.1.3. Pandemic Wind Down
    • 5.1.4. Viral Zeitqeist
  • 5.2. Factors Limiting Growth
    • 5.2.1. The Cost Curve Shrinks the Market
    • 5.2.2. Transmission Outlook
    • 5.2.3. Adoption Lag and Cost Control
  • 5.3. Diagnostic Technology Development
    • 5.3.1. The Multiplex Opportunity
    • 5.3.2. Shifting Role of Physicians in Diagnosis
    • 5.3.3. Diagnostics Moves Out of the Lab
    • 5.3.4. Biomarkers and Algorithms
    • 5.3.5. Rapid Testing Changing Medical Practice
    • 5.3.6. Genome Role and Big Data

6. Monkeypox Diagnostics - Recent Developments

  • 6.1. Recent Developments-Importance and How to Use This Section
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. U.S. to declare monkeypox a public health emergency
  • 6.3. BioGX Gets CE-IVD Mark for Multigene POC Test
  • 6.4. World Health Organization declares monkeypox a global emergency
  • 6.5. Quest Begins Offering Internally Developed Monkeypox Test
  • 6.6. CDC, Abbott, Roche, BioMérieux Get FDA 510(k) Clearances
  • 6.7. Commercial, Academic Labs Ramp Up Monkeypox Testing
  • 6.8. Becton Dickinson, CerTest Biotec Collaborate on Monkeypox MDx
  • 6.9. Sequence Coming In

7. Profiles of Key Companies

  • 7.1. Abbott Diagnostics
  • 7.2. Aegis Laboratories
  • 7.3. Applied DNA Sciences
  • 7.4. Beckman Coulter Diagnostics
  • 7.5. Becton, Dickinson and Company
  • 7.6. BioGX
  • 7.7. bioMérieux Diagnostics
  • 7.8. Bio-Rad Laboratories, Inc.
  • 7.9. Cepheid
  • 7.10. CerTest Biotec
  • 7.11. Creative Biogene
  • 7.12. Flow Health
  • 7.13. Labcorp
  • 7.14. Mayo Clinic Laboratories
  • 7.15. Quest Diagnostics
  • 7.16. Qiagen Gmbh
  • 7.17. Roche Molecular Diagnostics
  • 7.18. Siemens Healthineers
  • 7.19. Sonic Healthcare
  • 7.20. Sysmex
  • 7.21. Thermo Fisher Scientific Inc.

8. Monkeypox Global Diagnostic Markets Overview

  • 8.1. Monkeypox Diagnostics-Global Market Overview by Country
    • 8.1.1. Table-Global Market by Country
    • 8.1.2. Chart - Global Market by Country
  • 8.2. Global Monkeypox Diagnostics Markets Overview by Assay
    • 8.2.1. Table-Global Market by Assay
    • 8.2.2. Chart-Global Market by Assay-Segments Growth
    • 8.2.3. Chart-Global Market by Assay-Share by Year
    • 8.2.4. Chart-Global Market by Assay
    • 8.2.5. Chart-Global Market by Assay-Base Year
    • 8.2.6. Chart-Global Market by Assay-Final Year
  • 8.3. Global Monkeypox Diagnostics Markets Overview by Product
    • 8.3.1. Table-Global Market by Product
    • 8.3.2. Chart-Global Market by Product-Segments Growth
    • 8.3.3. Chart-Global Market by Product-Share by Year
    • 8.3.4. Chart-Global Market by Product
    • 8.3.5. Chart-Global Market by Product-Base Year
    • 8.3.6. Chart-Global Market by Product-Final Year
  • 8.4. Global Monkeypox Diagnostics Markets Overview by Place
    • 8.4.1. Table-Global Market by Place
    • 8.4.2. Chart-Global Market by Place-Segments Growth
    • 8.4.3. Chart-Global Market by Place-Share by Year
    • 8.4.4. Chart-Global Market by Place
    • 8.4.5. Chart-Global Market by Place-Base Year
    • 8.4.6. Chart-Global Market by Place-Final Year

9. Monkeypox Diagnostic Market-by Assay

  • 9.1. Monkeypox Diagnostic - PCR
    • 9.1.1. Table Monkeypox Diagnostic PCR-by Country
    • 9.1.2. Chart - Monkeypox Diagnostic PCR Growth
  • 9.2. Monkeypox Diagnostic-NGS
    • 9.2.1. Table Monkeypox Diagnostic NGS-by Country
    • 9.2.2. Chart - Monkeypox Diagnostic-NGS Growth
  • 9.3. Monkeypox Diagnostic-Rapid
    • 9.3.1. Table Monkeypox Diagnostic Rapid-by Country
    • 9.3.2. Chart - Monkeypox Diagnostic-Rapid Growth
  • 9.4. Monkeypox Diagnostic-Other Assay
    • 9.4.1. Table Monkeypox Diagnostic Other Assay-by Country
    • 9.4.2. Chart - Monkeypox Diagnostic-Other Assay Growth
  • 9.5. Monkeypox Diagnostic-Biomarker Other
    • 9.5.1. Table Monkeypox Diagnostic Biomarker Other-by Country
    • 9.5.2. Chart - Monkeypox Diagnostic-Biomarker Other Growth

10. Global Monkeypox Diagnostics Markets-By Product

  • 10.1. Monkeypox Diagnostic - Instrumentation
    • 10.1.1. Table Monkeypox Diagnostic Instrumentation-by Country
    • 10.1.2. Chart - Monkeypox Diagnostic Instrumentation Growth
  • 10.2. Monkeypox Diagnostic-Consumables
    • 10.2.1. Table Monkeypox Diagnostic Consumables-by Country
    • 10.2.2. Chart - Monkeypox Diagnostic Consumables
  • 10.3. Monkeypox Diagnostic-Software & Service
    • 10.3.1. Table Monkeypox Diagnostic Software & Service-by Country
    • 10.3.2. Chart - Monkeypox Diagnostic-Software & Service Growth

11. Global Monkeypox Diagnostics Markets-By Place

  • 11.1. Monkeypox Diagnostic - Hospital
    • 11.1.1. Table Monkeypox Diagnostic Hospital-by Country
    • 11.1.2. Chart - Monkeypox Diagnostic Hospital Growth
  • 11.2. Monkeypox Diagnostic-Clinic/POL
    • 11.2.1. Table Monkeypox Diagnostic Clinic/POL-by Country
    • 11.2.2. Chart - Monkeypox Diagnostic Clinic/POL Growth
  • 11.3. Monkeypox Diagnostic-Other Place
    • 11.3.1. Table Monkeypox Diagnostic Other Place-by Country
    • 11.3.2. Chart - Monkeypox Diagnostic Other Place

12. Appendices

  • 12.1. United States Medicare System: 2022 Clinical Laboratory Fees Schedule

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Five Factors Driving Growth
  • Table 3: Three Factors Limiting Growth
  • Table 4: Global Monkeypox Diagnostics Market by Country/Region
  • Table 5: Global Market by Assay
  • Table 7: Global Market by Product
  • Table 9: Global Market by Place
  • Table 1: Monkeypox Diagnostic PCR by Country
  • Table 1: Monkeypox Diagnostic NGS by Country
  • Table 13: Monkeypox Diagnostic Rapid by Country
  • Table 14: Monkeypox Diagnostic Other Assay by Country
  • Table 15: Monkeypox Diagnostic Biomarker Other by Country
  • Table 21: Monkeypox Diagnostic Instrumentation by Country
  • Table 22: Monkeypox Diagnostic Consumables by Country
  • Table 23: Monkeypox Diagnostic Software & Service by Country
  • Table 26: Monkeypox Diagnostic Hospital by Country
  • Table 26: Monkeypox Diagnostic Clinic/POL by Country
  • Table 27: Monkeypox Diagnostic Other Place by Country
  • Table 28: 2022 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Percentage of Patients with Comorbidity
  • Figure 2: Global Healthcare Spending Map
  • Figure 3: The Lab Test Pie - Wholesale and Retail
  • Figure 4: Deaths From Drug Resistant Infections 2050
  • Figure 5: Aggregate Age of World Population
  • Figure 6: Growth in Health Care Spending Developing World
  • Figure 7: Comparing The New Diagnostics and Traditional Testing
  • Figure 8: Global Market Share Chart
  • Figure 9: Monkeypox Diagnostics Market Segment Shift Base vs Final year
  • Figure 10: Monkeypox Diagnostics Market by Assay Base Year
  • Figure 11: Monkeypox Diagnostics Market by Assay Final Year
  • Figure 15: Monkeypox Diagnostics Market Segment Shift Base vs Final year
  • Figure 16: Monkeypox Diagnostics Market by Product Base Year
  • Figure 17: Monkeypox Diagnostics Market by Product Final Year
  • Figure 21: Monkeypox Diagnostics Market Segment Shift Base vs Final year
  • Figure 22: Monkeypox Diagnostics Market by Place Base Year
  • Figure 23: Monkeypox Diagnostics Market by Place Final Year
  • Figure 25: MONKEYPOX Diagnostics Syndromic POC Panel Growth
  • Figure 26: Monkeypox Diagnostic NGS Growth
  • Figure 27: Monkeypox Diagnostic Rapid Growth
  • Figure 28: Monkeypox Diagnostic Other Assay Growth
  • Figure 29: Monkeypox Diagnostic Biomarker Other Growth
  • Figure 35: Monkeypox Diagnostic Instrumentation Growth
  • Figure 36: MONKEYPOX Diagnostics Consumables
  • Figure 37: Monkeypox Diagnostic Software & Service Growth
  • Figure 40: Monkeypox Diagnostic GastroIntestinal Growth
  • Figure 40: Monkeypox Diagnostic Clinic/POL Growth
  • Figure 41: MONKEYPOX Diagnostics Other Place